Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Nat Biomed Eng ; 3(2): 137-146, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30911429

RESUMO

How common polymorphisms in noncoding genome regions can regulate cellular function remains largely unknown. Here we show that cardiac fibrosis, mimicked using a hydrogel with controllable stiffness, affects the regulation of the phenotypes of human cardiomyocytes by a portion of the long noncoding RNA ANRIL, the gene of which is located in the disease-associated 9p21 locus. In a physiological environment, cultured cardiomyocytes derived from induced pluripotent stem cells obtained from patients who are homozygous for cardiovascular-risk alleles (R/R cardiomyocytes) or from healthy individuals who are homozygous for nonrisk alleles contracted synchronously, independently of genotype. After hydrogel stiffening to mimic fibrosis, only the R/R cardiomyocytes exhibited asynchronous contractions. These effects were associated with increased expression of the short ANRIL isoform in R/R cardiomyocytes, which induced a c-Jun N-terminal kinase (JNK) phosphorylation-based mechanism that impaired gap junctions (particularly, loss of connexin-43 expression) following stiffening. Deletion of the risk locus or treatment with a JNK antagonist was sufficient to maintain gap junctions and prevent asynchronous contraction of cardiomyocytes. Our findings suggest that mechanical changes in the microenvironment of cardiomyocytes can activate the regulation of their function by noncoding loci.

2.
J Fam Pract ; 65(6): 412-21, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27474825

RESUMO

Single-agent therapy with a very potent or potent topical corticosteroid appears more effective than other topical agents, including vitamin D3 analogues, for treating scalp psoriasis.


Assuntos
Corticosteroides/uso terapêutico , Conservadores da Densidade Óssea/uso terapêutico , Psoríase/tratamento farmacológico , Dermatoses do Couro Cabeludo/tratamento farmacológico , Vitamina D/uso terapêutico , Administração Tópica , Dermatoses Faciais/tratamento farmacológico , Humanos , Vitamina D/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA